Brief: Catalyst Biosciences announces dismissal of JDS1 litigation

Gyre Therapeutics

19/08/2022 13:03

Aug 19 (Reuters) - Catalyst Biosciences Inc  CBIO.O :
    * CATALYST BIOSCIENCES, INC. ANNOUNCES DISMISSAL OF JDS1
LITIGATION
    * SAYS JDS1, LLC, ONE OF COMPANY'S STOCKHOLDERS, HAS
DISMISSED ITS
LAWSUITS AGAINST COMPANY
    * CATALYST BIOSCIENCES - JDS1 AND SOME OF ITS AFFILIATES
AGREED TO
CUSTOMARY STANDSTILL AND VOTING COMMITMENT, PARTIES HAVE ENTERED
INTO MUTUAL RELEASES
    * SAYS COMPANY HAS AGREED TO REIMBURSE JDS1 FOR SOME OF ITS
EXPENSES
    * SAYS BOARD OF DIRECTORS WILL BE MEETING TO DETERMINE
DETAILS OF
AN INITIAL DISTRIBUTION OF CAPITAL

Source text for Eikon:  ID:nGNXc80dsP 
Further company coverage:  CBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))